Health Care: Drugs

Arrowhead Pharmaceuticals Inc (ARWR: NASDAQ)

$7.13 0.09 | 1.28%
09/27/16 - 04:00 PM ET
Company Income Statement
Sep 2015 Sep 2014 Sep 2013 Sep 2012
Sales 382.00K 175.00K 290.27K 146.88K
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 382.00K 175.00K 290.27K 146.88K
Selling, General, and Administrative Expenses 34.72M 24.42M 11.69M 14.10M
Research & Development 47.27M 23.14M 8.71M 5.39M
Operating Income before D & A (EBITDA) -81.60M -47.38M -20.11M -19.34M
Depreciation & Amortization 3.45M 2.14M 1.88M 1.76M
Interest Income 729.16K 645.49K 0.00 35.97K
Other Income - Net 1.41M -8.39M -7.80M -817.24K
Special Income / Charges -20.29M -2.17M -1.31M 0.00
Total Income Before Interest Expenses (EBIT) -93.05M -59.51M -31.73M -22.12M
Interest Expense 0.00 0.00 97.91K 0.00
Pre-Tax Income -93.05M -59.51M -31.83M -22.12M
Income Taxes 2.40K 5.30K 0.00 0.00
Minority Interest 0.00 -95.22K -560.14K -984.79K
Net Income From Continuing Operations -91.94M -58.73M -31.70M -22.11M
Net Income From Discontinued Operations 0.00 0.00 -354.00 -80.00
Net Income From Total Operations -91.94M -58.73M -31.70M -22.11M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -91.94M -58.63M -31.14M -21.13M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-81.80M -56.55M -30.40M -22.11M
Preferred Dividends
Net Income Available To Common -91.94M -58.73M -31.70M -22.11M
Basic EPS from Continuing Ops. -1.60 -1.25 -1.30 -1.90
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.60 -1.25 -1.30 -1.90
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.60 -1.25 -1.30 -1.90
Basic Normalized Net Income/Share -1.43 -1.20 -1.24 -1.90
EPS fr Continuing Ops. -1.60 -1.25 -1.30 -1.90
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.60 -1.25 -1.30 -1.90
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.60 -1.25 -1.30 -1.90
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.43 -1.20 -1.24 -1.90
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ARWR

Latest ARWR Headlines from TheStreet

More Financial News for ARWR

Press Releases for ARWR

See All Press Releases

Partner Headlines for ARWR

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter